Brief: Piramal Pharma Says US FDA Issued A Form-483, With Four Observations
11/12/2025 15:37
Dec 11 (Reuters) - Piramal Pharma Ltd PIRM.NS: US FDA ISSUED A FORM-483, WITH FOUR OBSERVATIONS US FDA CONDUCTED INSPECTION OF LEXINGTON (KENTUCKY, USA) FACILITY Source text: ID:nBSE4pQ0vP Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington